Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10004-10016
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10004
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10004
Disease categories | Study object/model | Effect induced by autophagy | Mechanism (targets or pathways) | Ref. |
Liver injury | Iron overload (iron dextran) in LO2 cells | (-) Damage to hepatocytes, excessive autophagy, autophagosomes and apoptosis of hepatocytes by the iron overload | (-) LC3 II/I, (+) p62 | Xie et al[43] |
Liver and kidney injury | Cisplatin in rats | Protected against cisplatin-induced injury by (+) autophagy | (-) Autophagy-mediated NLRP3 | Qu et al[44] |
- Citation: Yang Y, Hong M, Lian WW, Chen Z. Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation. World J Clin Cases 2022; 10(28): 10004-10016
- URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10004.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10004